Bio-Gene Technology (ASX:BGT) FCF Yield % : -37.45 (As of Apr. 21, 2025)

View and export this data going back to 2017. Start your Free Trial

What is Bio-Gene Technology FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Bio-Gene Technology's Trailing 12-Month Free Cash Flow is A$-1.89 Mil, and Market Cap is A$5.03 Mil. Therefore, Bio-Gene Technology's FCF Yield % for today is -37.45%.

The historical rank and industry rank for Bio-Gene Technology's FCF Yield % or its related term are showing as below:

ASX:BGT' s FCF Yield % Range Over the Past 10 Years
Min: -78.11 Med: -11.7 Max: -4.37
Current: -37.45

During the past 7 years, the highest FCF Yield % of Bio-Gene Technology was -4.37%. The lowest was -78.11%. And the median was -11.70%.

ASX:BGT's FCF Yield % is ranked worse than
68.22% of 1498 companies
in the Biotechnology industry
Industry Median: -15.525 vs ASX:BGT: -37.45

Bio-Gene Technology's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Bio-Gene Technology FCF Yield % Historical Data

The historical data trend for Bio-Gene Technology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Gene Technology FCF Yield % Chart

Bio-Gene Technology Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

FCF Yield %

Get a 7-Day Free Trial

-8.37

-7.00

-10.03

-23.72

-27.97

Bio-Gene Technology Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Yield %	Get a 7-Day Free Trial										-23.45	-17.25	-28.92	-20.53	-20.14

Competitive Comparison of Bio-Gene Technology's FCF Yield %

For the Biotechnology subindustry, Bio-Gene Technology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Gene Technology's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Gene Technology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Bio-Gene Technology's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Bio-Gene Technology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Bio-Gene Technology's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-2.76	/	9.866738
	=	-27.97%

Bio-Gene Technology's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.872	*	2	/	8.658566
	=	-20.14%

Bio-Gene Technology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Bio-Gene Technology FCF Yield % Related Terms

Thank you for viewing the detailed overview of Bio-Gene Technology's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Gene Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Gene Technology Ltd (ASX:BGT) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000

Website

https://www.bio-gene.com.au

Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance. Its products are Flavocide and Qcide which include a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. The group's product has multiple applications across public health, crop protection, grain storage, and consumer use. It provides new options derived from nature to meet market demand for effective and safe pest management solutions.

Bio-Gene Technology Headlines

From GuruFocus

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

By Business Wire Business Wire • 12-20-2021